Advocacy Actions
Reference of Low-hanging Fruit for Medical Device Sector
On 23rd October, the medical device sector provided the low-hanging fruit list to the Delegation of the European Union to China.
Read moreAdvocacy Letter to the Ministry of Finance and the Ministry of Commerce on Buy China Issues
On 15th October, the medical device sector sent two advocacy letter to the Ministry of Finance and the Ministry of Commerce on Buy China issue.
Read moreEuropean Chamber Healthcare Equipment Working Group Rep. Presents “Buy China” policy issue at the EU Delegation to China
European Chamber Healthcare Equipment Working Group Rep. Presents “Buy China” policy issue at the EU Delegation to China
Read moreComments to the Centre for Medical Device Evaluation on Further Specification of the Clinical Evaluation Section of eRPS
On 30th September, the medical devices sector submitted comments to the Centre for Medical Device Evaluation on further specification of the Clinical Evaluation Section of eRPS.
Comments to the NMPA's Notice on Matters Related to the First Batch of Implementation of the Unique Device Identification of Medical Devices (Call for Comment)
On 25th September, the medical devices sector submitted comments to the National Medical Products Administration on the Notice on Matters Related to the First Batch of Implementation of the Unique Device Identification of Medical Devices (Call for Comment).
Read moreCOCIR and HCE Members Contribute the 10th China International Medical Device Regulatory(CIMDR) Forum in Suzhou
As the co-supporter of the 10th China International Medical Device Regulatory (CIMDR) Forum in Suzhou, COCIR and several members of the Healthcare Equipment Working Groups attended the conference as the moderator and speaker for plenary and sub-forums.
Read moreMeeting with the Centre for Medical Device Evaluation of the National Medical Product Administration on the Regulations on Random Inspection of Medical Devices Quality (Draft for Comments)
On 23rd September. the Centre for Medical Device Evaluation of the National Medical Products Administration held a meeting on Regulations on Random Inspection of Medical Devices Quality (Draft for Comments).
Read moreComments to the NMPA's Regulations on Expansive Clinical Trial of Medical Devices
On 20th September, the medical devices sector submitted comments to the National Medical Products Administration on the Regulations on Expansive Clinical Trial of Medical Devices.
Read moreAdvocacy Letter to the State Administration for Market Regulation on Procurement Issue in Guangxi Province
On 20th September, the medical device sector sent an advocacy letter to the Antitrust Office of the State Administration for Market Regulation on procurement issue in Guangxi province.
Read moreDITTA Chair Met with the Deputy Commissioner of NMPA
On 18th September, DITTA Chair met with the Deputy Commissioner of National Medical Products Administration.
Read more